PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...
The US Food and Drug Administration (FDA) has approved Abbott's TriClip Transcatheter Edge-to-Edge Repair (TEER) system to repair severe tricuspid regurgitation (TR), the company has announced. The ...
PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...
The publication of another small-scale study on MitraClip use in patients with tricuspid regurgitation shows promise for the treatment, yet experts caution that more feasibility data is still needed.
Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel transcatheter edge-to-edge repair device for the treatment of severe tricuspid ...
Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...
(RTTNews) - Abbott (ABT) said that the Circulatory System Devices Panel of the Medical Devices Advisory Committee for the U.S. Food and Drug Administration confirmed 13 to 1, with 0 abstention that ...
NEW ORLEANS -- Transcatheter edge-to-edge repair (TEER) of severely regurgitant tricuspid valves improved outcomes, largely in terms of quality of life, the TRILUMINATE Pivotal trial showed. That ...
The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...
Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors. Tricuspid regurgitation (TR) is ...
Edwards Lifesciences Corporation EW recently gained CE Mark for its PASCAL Precision transcatheter valve repair system used to treat mitral and tricuspid regurgitation. The PASCAL Precision system is ...
Tricuspid regurgitation is when blood flows backwards through the tricuspid valve because it does not close properly during systole. It can be caused by a problem with the valve itself (primary). But ...